- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lucid Diagnostics Inc (LUCD)
Lucid Diagnostics Inc stock price live, this page displays NASDAQ LUCD stock exchange data. View the LUCD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lucid Diagnostics Inc real time stock price chart below.
What Is the Lucid Diagnostics Inc Stock Price Today?
The Lucid Diagnostics Inc stock price today is 1.1800.
What Is the Stock Symbol for Lucid Diagnostics Inc?
The stock symbol for Lucid Diagnostics Inc is ""LUCD.""
What Stock Exchange Does Lucid Diagnostics Inc Trade On?
Lucid Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Lucid Diagnostics Inc a Good Stock to Buy?
Determining whether Lucid Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUCD quote. (ISIN: US54948X1090)
What Is the Lucid Diagnostics Inc Stock Price Today?
The Lucid Diagnostics Inc stock price today is 1.1800.
What Is the Stock Symbol for Lucid Diagnostics Inc?
The stock symbol for Lucid Diagnostics Inc is ""LUCD.""
What Stock Exchange Does Lucid Diagnostics Inc Trade On?
Lucid Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Lucid Diagnostics Inc a Good Stock to Buy?
Determining whether Lucid Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUCD quote. (ISIN: US54948X1090)
1.1800
+0.0200(+1.72%)
Real-time Data·
Fair Value
An estimate of a Lucid Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1550
1.2200
52 wk Range
0.7300
1.8000
LUCD Scorecard
Full Analysis
Quickly burning through cash
LUCD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Lucid Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.15501.2200
52 wk Range
0.73001.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LUCD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Lucid Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
3.6250
Upside
+207.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Lucid Diagnostics Inc Company Profile
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Lucid Diagnostics Inc SWOT Analysis
Market Disruption | Lucid Diagnostics aims to revolutionize BE-EAC screening with EsoGuard/EsoCheck technology, targeting a $25 billion U.S. market opportunity |
Financial Crossroads | Despite 179% YoY revenue growth, LUCD faces challenges with cash burn and revised 2025 revenue projections, reflecting market uncertainties |
Reimbursement Hurdles | Progress in clinical validation studies bolsters reimbursement efforts, but pricing pressures could impact future revenue and market adoption |
Strategic Outlook | Analysts set price targets between $2.00 and $3.00, as LUCD navigates growth challenges and explores potential market expansion opportunities |
Lucid Diagnostics Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue up 40% from Q1 to $1.2M; EPS beat at -$0.10 vs -$0.11 forecast; stock dips 1.1% despite earnings beat
- Secured first commercial coverage policy with Highmark Blue Cross Blue Shield; anticipates Medicare coverage draft by end of 2025
- Cash position strengthened to $31.1M after $16.1M public offering; quarterly burn rate improved to $10.3M
- Revenue recognition remains challenging with only 17% of billed amounts recognized; gross profit margins at -59.27%
- Analysts maintain strong buy consensus; price targets range from $2.00 to $7.75 despite current stock price of $0.9975
Last Updated: 13/08/2025, 14:50
Read Full TranscriptCompare LUCD to Peers and Sector
Metrics to compare | LUCD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUCDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −3.1x | −0.6x | |
PEG Ratio | −0.09 | −0.09 | 0.00 | |
Price/Book | −2.6x | 3.1x | 2.6x | |
Price / LTM Sales | 28.3x | 5.5x | 3.3x | |
Upside (Analyst Target) | 158.6% | 26.6% | 39.0% | |
Fair Value Upside | Unlock | 5.4% | 4.9% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.6250
(+207.20% Upside)
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.10 / -0.11
Revenue / Forecast
1.16M / 1.16M
People Also Watch
FAQ
What Stock Exchange Does Lucid Diagnostics Trade On?
Lucid Diagnostics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Lucid Diagnostics?
The stock symbol for Lucid Diagnostics is "LUCD."
What Is the Lucid Diagnostics Market Cap?
As of today, Lucid Diagnostics market cap is 103.93M.
What Is Lucid Diagnostics's Earnings Per Share (TTM)?
The Lucid Diagnostics EPS (TTM) is -0.98.
When Is the Next Lucid Diagnostics Earnings Date?
Lucid Diagnostics will release its next earnings report on 16 Nov 2025.
From a Technical Analysis Perspective, Is LUCD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lucid Diagnostics Stock Split?
Lucid Diagnostics has split 0 times.
How Many Employees Does Lucid Diagnostics Have?
Lucid Diagnostics has 72 employees.
What is the current trading status of Lucid Diagnostics (LUCD)?
As of 26 Aug 2025, Lucid Diagnostics (LUCD) is trading at a price of 1.18, with a previous close of 1.16. The stock has fluctuated within a day range of 1.16 to 1.22, while its 52-week range spans from 0.73 to 1.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.